Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Experimental & Clinical Cancer Research
Published in: Journal of Experimental & Clinical Cancer Research 1/2011

Open Access 01-12-2011 | Retraction Note

Retraction Note: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma

Authors: Linwei Li, Chunpeng Zhang, Xiaoyan Li, ShihHsin Lu, Yun Zhou

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2011

Login to get access

Excerpt

The authors have retracted this article [1] as there was a large overlap with a previously published article in International Journal of Cancer[2]. Dr Lu ShihHsin, although listed as an author, was not aware of the publication in Journal of Experimental & Clinical Cancer Research and the grant reference number stated in the acknowledgements was incorrectly applied to this article. …
Literature
1.
Li Linwei, Zhang Chunpeng, Li Xiaoyan, Lu ShihHsin, Zhou Yun: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. Journal of Experimental & Clinical Cancer Research. 2010, 29: 133-CrossRef
2.
Li LW, Yu XY, Yang Y, Zhanag CP, Guo LP, Lu SH: Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer. 2009, 125: 1505-1513. 10.1002/ijc.24513.CrossRefPubMed
Metadata
Title
Retraction Note: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma
Authors
Linwei Li
Chunpeng Zhang
Xiaoyan Li
ShihHsin Lu
Yun Zhou
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2011
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-30-19

Other articles of this Issue 1/2011

Journal of Experimental & Clinical Cancer Research 1/2011 Go to the issue

Research

Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients

Research

Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells

Research

Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway

Review

Oncogene addiction in gliomas: Implications for molecular targeted therapy

Research

Activation of the hedgehog pathway in chronic myelogeneous leukemia patients

Research

Folic Acid supplementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits